Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism

被引：0
|
作者：
Tomasz Hryszko
Szymon Brzosko
Alicja Rydzewska-Rosolowska
Ewa Koc-Zorawska
Michal Mysliwiec
机构：
[1] Medical University of Bialystok,Department of Nephrology and Transplantation
来源：
International Urology and Nephrology | 2012年 / 44卷
关键词：
Bone metabolism; Cinacalcet; FGF-23; Hemodialysis; Secondary hyperparathyroidism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1479 / 1486
页数：7
相关论文
共 43 条
  • [41] Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study
    Cozzolino, Mario
    Ketteler, Markus
    Martin, Kevin J.
    Sharma, Amit
    Goldsmith, David
    Khan, Samina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 899 - 905
  • [42] Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism
    Ogata, Hiroaki
    Koiwa, Fumihiko
    Shishido, Kanji
    Takahashi, Keiko
    Ito, Hidetoshi
    Kinugasa, Eriko
    Taguchi, Susumu
    THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 (03) : 202 - 209
  • [43] Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism
    Bojan Kovacevic
    Mile Ignjatovic
    Vladan Zivaljevic
    Vladimir Cuk
    Milena Scepanovic
    Zaklina Petrovic
    Ivan Paunovic
    Langenbeck's Archives of Surgery, 2012, 397 : 413 - 420
12345